Fiscal year ending 2024. Filed on February 11, 2025.
504 Rxr Plaza
Uniondale, New York 11556
Marc Lustgarten Pancreatic Cancer Foundation (EIN: 31-1611837), also known as Lustgarten Foundation, has filed an IRS Form 990 between fiscal years 2016 and 2024. In its fiscal year 2024 IRS Form 990 filing, Marc Lustgarten Pancreatic Cancer Foundation, a 501(c)(3) charitable organization, reported compensation for 8 out of 28 total employees. Among the employees shown here, the average compensation is $304,134. The highest compensated employee at Marc Lustgarten Pancreatic Cancer Foundation is Linda Tantawi with fiscal year 2024 compensation of $520,974.
Revenue
Expenses
Employee compensation
THE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. SEE SCHEDULE OTHE LUSTGARTEN FOUNDATION IS BOLDY LEADING THE WAY THROUGH HOPE AND INNOVATION, TURNING FEAR INTO ACTION THROUGH EDUCATION AND EMPOWERMENT, AND ADVANCING THE BEST SCIENCE TO TRANSFORM PANCREATIC CANCER INTO A CURABLE DISEASE. THE FOUNDATION FOCUSES ON TRANSLATING OUR UNDERSTANDING OF THE UNDERLYING BIOLOGY OF PANCREATIC CANCER INTO CLINICAL APPLICATIONS TO CHANGE, EXTEND, AND ULTIMATELY SAVE PATIENTS' LIVES. IN FY24, THE FOUNDATION AWARDED $21.8 MILLION TO FUEL CUTTING-EDGE PANCREATIC CANCER RESEARCH, INCLUDING 10 NEW GRANTS TO RESEARCHERS AT SEVEN LEADING INSTITUTIONS. RESEARCH EFFORTS ARE CONCENTRATED ON THREE KEY PILLARS: EARLY DETECTION AND INTERCEPTION, DRUG DEVELOPMENT, AND PERSONALIZED MEDICINE.
Be the first to know when new IRS Form 990 data is published for this organization.